THROMBOCYTOPENIA IS A THROMBOTIC RISK FACTOR IN PATIENTS WITH POSITIVE ANTIPHOSPHOLIPID ANTIBODIES WITHOUT CLINICAL CRITERIA OF THE DISEASE?

被引：0
|
作者：
Demetrio Pablo, R. [1 ]
Munoz, P. [2 ]
Calvo-Rio, V. [3 ]
Riancho-Zarrabeitia, L. [3 ]
Lopez-Hoyos, M. [4 ]
Martinez-Taboada, V. M. [3 ]
机构：
[1] Hosp Univ Marques de Valdecilla, IDIVAL, Fac Med, UC,Ophtalmol, Santander, Spain
[2] Hosp Univ Marques de Valdecilla, IDIVAL, Fac Med, UC,Primary Care Management, Santander, Spain
[3] Hosp Univ Marques de Valdecilla, IDIVAL, Fac Med, UC,Rheumatol, Santander, Spain
[4] Hosp Univ Marques de Valdecilla, IDIVAL, Fac Med, UC,Immunol, Santander, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.5274
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0308
引用
收藏
页码：779 / 779
页数：1
相关论文
共 50 条
  • [41] Rituximab therapy for refractory thrombocytopenia in patients with antiphospholipid antibodies
    Vazquez Gomez, Felisa
    Prieto Arce, Maria
    Ignacio Gonzalez-Granado, Luis
    Enriquez Merayo, Eugenia
    de Inocencio Arocena, Jaime
    ANALES DE PEDIATRIA, 2017, 87 (01): : 51 - 53
  • [42] SPECIFIC ANTIPLATELET AUTOANTIBODIES IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES AND THROMBOCYTOPENIA
    FABRIS, F
    STEFFAN, A
    CORDIANO, I
    BORZINI, P
    LUZZATTO, G
    RANDI, ML
    GIROLAMI, A
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1994, 53 (04) : 232 - 236
  • [43] Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients
    Tarr, T.
    Lakos, G.
    Bhattoa, H. P.
    Shoenfeld, Y.
    Szegedi, G.
    Kiss, E.
    LUPUS, 2007, 16 (01) : 39 - 45
  • [44] Livedo, dementia, thrombocytopenia, and endotheliitis without antiphospholipid antibodies: Seronegative antiphospholipid-like syndrome
    Duval, Arnaud
    Darnige, Luc
    Glowacki, Francois
    Copin, Marie-Christine
    De Lassalle, Elisabeth Martin
    Delaporte, Emmanuel
    Auxenfants, Eric
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 61 (06) : 1076 - 1078
  • [45] The influence of anti-tissue factor pathway inhibitor (TFPI) antibodies on thrombin generation (TG) in thrombotic patients with and without antiphospholipid syndrome
    Efthymiou, M.
    Mackie, I. J.
    Lawrie, A. S.
    Machin, S. J.
    Cohen, H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 597 - 597
  • [46] Arterial elasticity in the patients with antiphospholipid syndrome or positive antiphospholipid antibodies
    Reitblat, T
    Polishchuk, I
    Zamir, D
    Isakov, I
    Oren, S
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 326 - 326
  • [47] ANTIPHOSPHOLIPID ANTIBODY SYNDROME AS A RISK FACTOR FOR COPD: MULTIPLICATIVE INTERACTION EFFECTS OF POSITIVE ANTIPHOSPHOLIPID ANTIBODIES WITH LOW TESTOSTERONE
    Nowshad, G.
    Ayass, M. A.
    Mosleh, L. Abi
    Zhu, K.
    Viswanathan, K.
    Wilgers, K.
    CHEST, 2019, 155 (04) : 216A - 216A
  • [48] Factor V Leiden increases the risk of thrombosis in patients with antiphospholipid antibodies
    Simantov, R
    Lo, SK
    Salmon, JE
    Sammaritano, LR
    Silverstein, RL
    THROMBOSIS RESEARCH, 1996, 84 (05) : 361 - 365
  • [49] THROMBOCYTOPENIA AND THYROID-DISEASE - A POSSIBLE RELATIONSHIP WITH ANTIPHOSPHOLIPID ANTIBODIES
    ALARCONSEGOVIA, D
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 1988, 40 (01): : 113 - 113
  • [50] Risk of thrombosis in patients with antiphospholipid antibodies and factor V Leiden mutation
    Pablos, JL
    Caliz, RA
    Carreira, PE
    Atsumi, T
    Serrano, L
    Amengual, O
    Santiago, B
    Khamashta, MA
    Hughes, GRV
    Gomez-Reino, JJ
    JOURNAL OF RHEUMATOLOGY, 1999, 26 (03) : 588 - 590
12345